Technology-enabled longitudinal monitoring of patient-reported outcomes (PROs) to individualize care of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results